CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $87,000 | -8.4% | 20,143 | +24.0% | 0.06% | -11.6% |
Q2 2020 | $95,000 | -11.2% | 16,238 | -33.5% | 0.07% | -27.4% |
Q1 2020 | $107,000 | -35.5% | 24,429 | 0.0% | 0.10% | -35.4% |
Q4 2019 | $166,000 | -1.2% | 24,429 | -28.9% | 0.15% | -10.9% |
Q3 2019 | $168,000 | -27.3% | 34,344 | +9.8% | 0.16% | -21.4% |
Q2 2019 | $231,000 | +5.5% | 31,284 | +15.9% | 0.21% | -8.7% |
Q1 2019 | $219,000 | +9.0% | 26,994 | +5.9% | 0.23% | +8.5% |
Q4 2018 | $201,000 | – | 25,494 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |